Transcatheter Closure of Congenital Ventricular Septal Defects: Experience with Various Devices

Journal of Interventional Cardiology - Tập 16 Số 1 - Trang 83-91 - 2003
Ramesh Arora1, Vijay Trehan1, Ashish Kumar1, Dinesh Kumar1, Madhuri Nigam1
1From the Departments of Cardiology and Cardiothoracic Surgery, G. B. Pant Hospital, University of Delhi, New Delhi, India

Tóm tắt

Transcatheter closure of congenital ventricular septal defect (VSD) using various devices is gaining acceptance in selected cases of perimembranous and muscular defects, avoiding the inherent risks of cardiopulmonary bypass. The procedure was attempted in 137 patients having congenital defects using Rashkind Umbrella Device (RUD) in 29 patients, Amplatzer ventricular septal occluder (AVSO) in 107 patients, and Detachable Coil in one. All patients were selected using stringent criteria by detailed transthoracic echocardiography and/or transesophageal echocardiography. The location of VSD was perimembranous in 91 patients and was muscular trabecular in 46 patients. Seven patients had left ventricle (LV) to right atrium (RA) communication. Thirty‐five patients with perimembranous and two with muscular VSD had aneurysm formation. The patients were 3 to 33 years old, and the diameter of VSD ranged from 3 to 12 mm. The pulmonary to systemic flow ratio was ≥2:1 in 47 (34.3%) patients. The procedure was successful in 130 (94.8%) patients, with a success rate of 86.2% with RUD and 97.1% with AVSO. Residual shunt at 24 hours was seen in eight (32%) patients with RUD and in one patient (0.9%) with AVSO. Three (2.8%) developed transient bundle branch block, and two (1.9%) patients had complete heart block. New tricuspid stenosis and tricuspid regurgitation was observed in one patient each with AVSO. After immediate balloon dilatation, the mean pressure gradient across tricuspid valve decreased from 11 to 3 mmHg in the patient with tricuspid stenosis. On a follow‐up of 1 to 66 (mean 35.2 ± 10.7) months, the device was in position in all. None developed late conduction defect, aortic regurgitation, infective endocarditis, or hemolysis. At 9‐month follow‐up, the mean pressure gradient across the tricuspid valve was 3 mmHg in the patient with tricuspid stenosis. Complete occlusion of the shunt was achieved in 129 (99.2%) patients. One patient with RUD having persistent residual shunt underwent a second procedure with AVSO. Three out of 107 patients with AVSO had an unsuccessful procedure where the defect was perimembranous with a superior margin of defect less than 3 mm away from the aortic valve, and the specially designed perimembranous AVSO had to be retrieved because of hemodynamic compromise due to significant acute aortic regurgitation, whereas in all others, the defect was either ≥3 mm away from the aortic valve or had aneurysm formation. All seven patients with LV to RA communication showed complete abolition of the shunt. Thus, in properly selected cases of perimembranous and muscular ventricular septal defects, the transcatheter closure is safe and efficacious using appropriate devices. The success rate is higher with AVSO compared with the previously used devices, as well as more successful for the muscular defects than those that are perimembranous in location. (J Interven Cardiol 2003;16:83–91)

Từ khóa


Tài liệu tham khảo

10.1161/01.CIR.78.2.361

10.1002/ccd.1810170311

Nykanen DG, 1993, Transcatheter occlusion of ventricular septal defects: Experience in 80 patients with congenital heart disease, Circulation, 88, I‐532

10.1136/hrt.72.4.368

10.1136/hrt.77.3.276

10.1002/(SICI)1522-726X(199901)46:1<43::AID-CCD12>3.0.CO;2-T

10.1161/01.CIR.100.3.320

10.1016/S0735-1097(99)00011-X

10.1002/(SICI)1522-726X(200002)49:2<167::AID-CCD11>3.0.CO;2-S

10.1136/hrt.81.4.438

Sideris EB, 2001, The role of the “Sideris” devices in the occlusion of ventricular septal defects, Curr Interv Cardiol Rep, 3, 349

10.1016/S0002-8703(99)70122-5

Goh TH, 2001, Rashkind and Clamshell device closure of ventricular septal defect, Curr Interv Cardiol Rep, 3, 354

10.1016/0002-9149(86)90903-3

10.1136/hrt.82.3.395

10.1136/hrt.55.1.45

Graham TP, 1995, Moss and Adams Heart Disease in Infants, Children, and Adolescents, 724

10.1016/0003-4975(95)90006-3

Gersony WM, 1993, Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis or ventricular septal defects, Circulation, 87, 1121

Karpawich PP, 1981, Ventricular septal defect with associated aortic valve insufficiency: Progression of insufficiency and operative results in young children, J Thorac Cardiovasc Surg, 82, 182, 10.1016/S0022-5223(19)39352-3

10.1136/hrt.33.2.246

10.1016/0735-1097(94)90671-8

10.1007/s002469900093

10.1097/00000539-199506000-00002

10.1056/NEJM199105093241903